An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

A recent study on kidney disease found that nearly half of patients with advanced chronic kidney disease (CKD) in the country lost their jobs due to their deteriorating health conditions.

Organ donation registration can be completed through the Ohio Bureau of Motor Vehicles. Living donors can contact one of two ...

An unusual swelling in the legs and feet could indicate the onset of kidney damage. When the kidneys struggle to eliminate ...

Our study thus confirmed what was found in people of African descent in the US: the genetic origin underpinning the excess ...

A man from Nailsea claims he lost his job at a building site after leaving work early for kidney dialysis treatment. | ITV ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with ...